Article Information
- Received August 15, 2003
- Revision received November 18, 2003
- Accepted November 20, 2003
- First published February 4, 2004.
- Version of record published February 4, 2004.
Author Information
Author contributions
Disclosures
- Received August 15, 2003.
- Revision received November 18, 2003.
- Accepted November 20, 2003.
-
↵a For genes of interest with FC or CV outside of these cutoffs, the outlying values are shown in bold. Special consideration should be paid to the lower-ranked genes with a high CV (>1.0), low basal expression (baseline signal, <300), or small fold change (<2) because of the potential for bias from two rounds of amplification.
This work was supported by Grants ES08089 (J.A.J.), ES10042 (J.A.J.), and ES09090 (Environmental Health Sciences Center) from the National Institute of Environmental Health Sciences. We thank Matthew Slattery and the Microarray Core Facility for conducting the gene array hybridizations; Kathy Schell and the Flow Cytometry Core Facility for cell sorting and technical assistance; Andy Shih and Dr. Tim Murphy for their assistance in the preparation of adenovirus; Dr. Albee Messing for GFAP–GFP mice; and Dr. Kaiman Chan and Dr. Yuet Wai Kan for Nrf2 KO mice. Special thanks to Jong-Min Lee for Nrf2 KO breeding partners; Thor Stein and Jiang Li for assistance with microarray data analyses; and Marcus Calkins, Julie Kern, Jon Kern, Jong-Min Lee, Jiang Li, Thor Stein, and Maria Spletter for intellectual and scientific input.
Correspondence should be addressed to Dr. Jeffrey A. Johnson, University of Wisconsin-Madison, 6125 Rennebohm Hall, School of Pharmacy, 777 Highland Avenue, Madison, WI 53705-2222. E-mail: jajohnson{at}pharmacy.wisc.edu.
DOI:10.1523/JNEUROSCI.3817-03.2004
Copyright © 2004 Society for Neuroscience 0270-6474/04/241101-12$15.00/0
Online Impact